Cosciens Biopharma Inc (CSCI) Return on Investment ROI from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, average high and low, overall ranking from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Cosciens Biopharma Inc   (CSCI)


Cosciens Biopharma Inc's ROI from its fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Cosciens Biopharma Inc's ROI in the fourth quarter of 2025?
Cosciens Biopharma Inc recorded a cumulative net loss of $-10 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on investment (ROI) of -46.55%.

Within the Consumer Non Cyclical sector 158 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2025 from 0 to 4122.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Investment Change TTM -0.78 % -5.57 % 22.44 % 102.33 % 434.01 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 18 20 24 28 15
Return On Investment (TTM) -46.55 % -109.17 % -126.59 % -116.72 % -106.52 %
CSCI's Overall Ranking # 4122 # 0 # # #
Seq. Investment Change TTM 3.43 % -0.69 % -3.28 % -0.13 % -1.57 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -10 -23 -27 -26 -24

CSCI Company Profile >> Back to CSCI Roi Comparisons >> See Annual CSCI Return On Investment



Return On Investment CSCI's Ranking
Within: No.
Industry # 24
Sector # 159
Overall # 4122

Return On Investment Statistics
High Average Low
21.57 %
-71.22 %
-172.1 %
(Dec 31 2018)   (Dec 31 2022)







Financial Statements
Cosciens Biopharma Inc's IV. Quarter Investments $ 18 Millions CSCI's Balance sheet
Cosciens Biopharma Inc's IV. Quarter Income $ -2 Millions Quarterly CSCI's Income Statement
CSCI's Income by Division See CSCI's Income by Division


CSCI Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 1 2 16 1 54
Y / Y Investment Growth -18.61 % -89.55 % 2015.71 % -98.58 % 271.94 %
Net Income in Millions -10 -15 -3 3 -8
Y / Y Net Income Growth - - - - -
Annual Return On Investment -747.33 % -898.94 % -21.39 % 447.79 % -15.44 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Personal & Household Products Industry Roi Trends and Statistics
Consumer Non Cyclical Sector Return On Investment Statistics
Roi Trends for overall market
CSCI's Roi Ratio versus Personal & Household Products Industry, Consumer Non Cyclical Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CSCI's Competitors
Subscribers only: Roi for Cosciens Biopharma Inc's Suppliers
Subscribers only: Return On Investment for CSCI's Customers

Other Ratios
CSCI's Roa CSCI's Inventory Turnover Ratio CSCI's Growth Rates CSCI's Dividend Statistics
CSCI's Profitability Ratios CSCI's Asset Turnover Ratio CSCI's Dividend Growth
CSCI's Roe CSCI's Valuation Ratios CSCI's Financial Strength Ratios CSCI's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2025, within Consumer Non Cyclical Sector ROI

Date modified: 2026-09-18T14:10:37+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.